FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)

View source ↗

Summary

FDA approved a supplemental application for levothyroxine sodium from Lannett Company, Inc., supporting the generic product's continued market availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Goiter
• Hypothyroidism
• Myxedema Coma

Drugs mentioned

• Levothyroxine Sodium (generic) (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)